Cosmos Health Inc. (COSM)Healthcare | Medical Distribution | Thessaloniki, Greece | NasdaqCM
0.31 USD
+0.02
(5.364%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 0.32 +0.01 (2.789%) ⇧ (July 13, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:24 a.m. EDT
The investment case for Cosmos Health is currently broken by a severe deterioration in both fundamentals and market sentiment. While the company boasts impressive top-line growth of 30% and is aggressively executing a share buyback program, these positives are completely overshadowed by a catastrophic collapse in profitability. The business is burning cash, with operating cash flow and free cash flow both deeply negative, while return on equity has plummeted to nearly -92%. This financial distress is reflected in the stock's brutal multi-year performance, which has erased over 92% of its value since 2016, driven by a massive crash in 2019 and another steep decline in 2025. The market has priced this reality into the stock, resulting in a valuation that looks cheap on paper but is dangerous in practice. With negative earnings and negative cash flow, traditional multiples like P/E are meaningless, and the low price-to-book ratio is misleading given the company's inability to generate capital returns. The options market confirms this pessimism, with traders stacking put options to hedge against further drops rather than betting on a rebound. Until the company can demonstrate a path to positive cash flow and stabilize its balance sheet, the aggressive buybacks are merely a distraction from a fundamentally failing operation. The risk of permanent capital loss remains high. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.339424 |
| AutoETS | 0.359158 |
| AutoARIMA | 0.359914 |
| MSTL | 0.373768 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 31% |
| H-stat | 15.34 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.583 |
| Excess Kurtosis | -0.76 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 87.866 |
| Revenue per Share | 1.955 |
| Market Cap | 19,144,978 |
| Forward P/E | 4.41 |
| Beta | 4.15 |
| Profit Margins | -30.41% |
| Previous Name | Cosmos Holdings Inc. |
| Website | https://www.cosmoshealthinc.com |
As of July 11, 2026, 6:24 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put volume and open interest significantly exceed call activity across all expirations, with deep out-of-the-money puts (strikes of 2.5 and 5.0) seeing notable accumulation relative to the tiny call counterparties. Implied volatility is elevated for puts compared to calls, indicating a fear premium where traders are paying to insure against further declines. The lack of meaningful call open interest suggests the market views any potential recovery as highly unlikely in the near term.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.40688258 |
| Address1 | 5 Agiou Georgiou Str, Pilea |
| All Time High | 23.84 |
| All Time Low | 0.068 |
| Ask | 0.3054 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 20,947,580 |
| Average Daily Volume3 Month | 8,681,165 |
| Average Volume | 8,681,165 |
| Average Volume10Days | 20,947,580 |
| Beta | 4.148 |
| Bid | 0.0223 |
| Bid Size | 30 |
| Book Value | 0.398 |
| City | Thessaloniki |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Greece |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.3084 |
| Current Ratio | 1.083 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.3493 |
| Day Low | 0.2957 |
| Debt To Equity | 87.866 |
| Display Name | Cosmos Health |
| Dividend Date | 1,511,222,400 |
| Earnings Timestamp End | 1,744,821,915 |
| Earnings Timestamp Start | 1,744,821,915 |
| Ebitda | -16,500,105 |
| Ebitda Margins | -0.23746 |
| Enterprise To Ebitda | -2.038 |
| Enterprise To Revenue | 0.484 |
| Enterprise Value | 33,630,816 |
| Eps Forward | 0.07 |
| Eps Trailing Twelve Months | -0.66 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.26462 |
| Fifty Day Average Change | 0.04378 |
| Fifty Day Average Change Percent | 0.16544478 |
| Fifty Two Week Change Percent | -40.68826 |
| Fifty Two Week High | 1.32 |
| Fifty Two Week High Change | -1.0116 |
| Fifty Two Week High Change Percent | -0.7663636 |
| Fifty Two Week Low | 0.162 |
| Fifty Two Week Low Change | 0.1464 |
| Fifty Two Week Low Change Percent | 0.90370375 |
| Fifty Two Week Range | 0.162 - 1.32 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,279,891,800,000 |
| Float Shares | 33,930,598 |
| Forward Eps | 0.07 |
| Forward P E | 4.4057145 |
| Free Cashflow | -11,263,221 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 163 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.103999995 |
| Gross Profits | 7,226,947 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.33985 |
| Held Percent Institutions | 0.05094 |
| Implied Shares Outstanding | 62,078,397 |
| Industry | Medical Distribution |
| Industry Disp | Medical Distribution |
| Industry Key | medical-distribution |
| Ipo Expected Date | 2,022-02-28 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,511,222,400 |
| Last Split Factor | 1:10 |
| Long Business Summary | Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece. |
| Long Name | Cosmos Health Inc. |
| Market | us_market |
| Market Cap | 19,144,978 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_247762948 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -21,132,324 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 18,170,346 |
| Number Of Analyst Opinions | 1 |
| Open | 0.3 |
| Operating Cashflow | -9,328,364 |
| Operating Margins | -0.121829994 |
| Payout Ratio | 0.0 |
| Phone | 312 536 3102 |
| Post Market Change | 0.008599997 |
| Post Market Change Percent | 2.7885852 |
| Post Market Price | 0.317 |
| Post Market Time | 1,783,987,198 |
| Prev Name | Cosmos Holdings Inc. |
| Previous Close | 0.2927 |
| Price Hint | 4 |
| Price To Book | 0.7748744 |
| Price To Sales Trailing12 Months | 0.27551815 |
| Profit Margins | -0.30412 |
| Quick Ratio | 0.631 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0157 |
| Regular Market Change Percent | 5.36386 |
| Regular Market Day High | 0.3493 |
| Regular Market Day Low | 0.2957 |
| Regular Market Day Range | 0.2957 - 0.3493 |
| Regular Market Open | 0.3 |
| Regular Market Previous Close | 0.2927 |
| Regular Market Price | 0.3084 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 15,201,753 |
| Return On Assets | -0.18706 |
| Return On Equity | -0.92324996 |
| Revenue Growth | 0.307 |
| Revenue Per Share | 1.955 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 62,078,397 |
| Shares Percent Shares Out | 0.0764 |
| Shares Short | 4,744,953 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 890,287 |
| Short Name | Cosmos Health Inc. |
| Short Percent Of Float | 0.1007 |
| Short Ratio | 0.3 |
| Source Interval | 15 |
| Symbol | COSM |
| Target High Price | 4.5 |
| Target Low Price | 4.5 |
| Target Mean Price | 4.5 |
| Target Median Price | 4.5 |
| Total Cash | 548,927 |
| Total Cash Per Share | 0.01 |
| Total Debt | 17,420,672 |
| Total Revenue | 69,487,176 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.66 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.49767 |
| Two Hundred Day Average Change | -0.18926999 |
| Two Hundred Day Average Change Percent | -0.38031223 |
| Type Disp | Equity |
| Volume | 15,201,753 |
| Website | https://www.cosmoshealthinc.com |
| Zip | 55,438 |